2Nilsson J, Fredrikson NG, Schiopu A, et al. Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease[ J]. Curr Pharm Des,2007,13 : 1021 - 1030.
4Shim JY, Kim YJ, Lee HS. Effects of soybean isoflavone extract on the plasma lipid profiles and antioxidant enzyme activity in streptozotocin-induced diabetic rats[ J]. Nutr Res Pract,2008 ,2 :218 - 226.
5Balmir F, Staack R, Jeffrey E, et al. An extract of soy flour influences serum cholesterol and thyroid hormones in rats and hamsters [J]. J Nutr, 1996,126:3046 - 3053.
6Uesugi T, Toda T, Tsuji K, et al Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy isoflavones, daidzin, genistin, and glycitin [ J ]. Biol Pharm Bull, 2001, 24:368 - 372.
7Kojima T,Uesugi T,Toda T,et al. Hypolipidemic action of the soybean isoflavones genistein and genistin in glomerulonephritic rats[ J]. Lipids, 2002,37:261 - 265.
9Asakura L, Cazita PM, Harada LM, et al. Soy protein containing isoflavones favorably influences macrophage lipoprotein metabolism but not the development of atherosclerosis in CETP transgenic mice [ J]. Lipids, 2006,41:655 - 662.
10Wagner JD, Schwenke DC, Greaves KA, et al. Soy protein with isoflavones, but not an isoflavone-rich supplement, improves arterial low-density lipoprotein metabolism and atherogenesis [ J ]. Arterioscler Thromb Vasc Biol, 2003,23:2241 -2246.
8Rufer C E, Kulling S E. Antioxidant activity of isoflavones and their major metabolites using different in vitro assays [ J ]. J Agric Food Chem, 2006, 54(8): 2926-2931.
9Ahmad I U, Forman J D, Sarkar F, et al. Reduction of adverse events by soy isoflavones in patients undergoing external beam radiation therapy for prostate cancer[J]. Int J Radiat Oncol Biol Phys, 2008, 72: S318.
10Raffoul J J, Sarkar F H, Hillman G G. Radiosensitization of prostate cancer by soy isoflavones [ J]. Curr Cancer Drug Targets, 2007, 7 (8) : 759 - 765.
